Inozyme Pharma
INZY49
$3.95arrow_drop_down0.25%-$0.00
Penny Stock
INZY49
$3.95
arrow_drop_down0.25%Performance History
There's no data available for key stats
There's no data available for ratios/profitability stats
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Inozyme Pharma (INZY)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Douglas A. Treco Ph.D.
- Headquarters
- Boston
- Employees
- 56
- Exchange
- NASDAQ
Keep an eye on Inozyme Pharma
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.